FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q46138991> ?p ?o ?g. }

• Q46138991 description "2009 nî lūn-bûn" @default.
• Q46138991 description "2009年の論文" @default.
• Q46138991 description "2009年学术文章" @default.
• Q46138991 description "2009年学术文章" @default.
• Q46138991 description "2009年学术文章" @default.
• Q46138991 description "2009年学术文章" @default.
• Q46138991 description "2009年学术文章" @default.
• Q46138991 description "2009年学术文章" @default.
• Q46138991 description "2009年學術文章" @default.
• Q46138991 description "2009年學術文章" @default.
• Q46138991 description "2009年學術文章" @default.
• Q46138991 description "2009年學術文章" @default.
• Q46138991 description "2009年學術文章" @default.
• Q46138991 description "2009년 논문" @default.
• Q46138991 description "article científic" @default.
• Q46138991 description "article scientific" @default.
• Q46138991 description "article scientifique" @default.
• Q46138991 description "articol științific" @default.
• Q46138991 description "articolo scientifico" @default.
• Q46138991 description "artigo científico" @default.
• Q46138991 description "artigo científico" @default.
• Q46138991 description "artigo científico" @default.
• Q46138991 description "artikel ilmiah" @default.
• Q46138991 description "artikull shkencor" @default.
• Q46138991 description "artikulong pang-agham" @default.
• Q46138991 description "artykuł naukowy" @default.
• Q46138991 description "artículo científico publicado en 2009" @default.
• Q46138991 description "artículu científicu" @default.
• Q46138991 description "bilimsel makale" @default.
• Q46138991 description "bài báo khoa học" @default.
• Q46138991 description "naučni članak" @default.
• Q46138991 description "scienca artikolo" @default.
• Q46138991 description "scientific article published in March 2009" @default.
• Q46138991 description "scientific article published in March 2009" @default.
• Q46138991 description "scientific article published in March 2009" @default.
• Q46138991 description "teaduslik artikkel" @default.
• Q46138991 description "tieteellinen artikkeli" @default.
• Q46138991 description "tudományos cikk" @default.
• Q46138991 description "vedecký článok" @default.
• Q46138991 description "vetenskaplig artikel" @default.
• Q46138991 description "videnskabelig artikel" @default.
• Q46138991 description "vitenskapelig artikkel" @default.
• Q46138991 description "vitskapeleg artikkel" @default.
• Q46138991 description "vědecký článek" @default.
• Q46138991 description "wetenschappelijk artikel" @default.
• Q46138991 description "wissenschaftlicher Artikel" @default.
• Q46138991 description "επιστημονικό άρθρο" @default.
• Q46138991 description "мақолаи илмӣ" @default.
• Q46138991 description "наукова стаття, опублікована в березні 2009" @default.
• Q46138991 description "научна статия" @default.
• Q46138991 description "научная статья" @default.
• Q46138991 description "научни чланак" @default.
• Q46138991 description "научни чланак" @default.
• Q46138991 description "מאמר מדעי" @default.
• Q46138991 description "مقالة علمية نشرت في مارس 2009" @default.
• Q46138991 description "মার্চ ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q46138991 description "บทความทางวิทยาศาสตร์" @default.
• Q46138991 description "სამეცნიერო სტატია" @default.
• Q46138991 name "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features." @default.
• Q46138991 name "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features." @default.
• Q46138991 type Item @default.
• Q46138991 label "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features." @default.
• Q46138991 label "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features." @default.
• Q46138991 prefLabel "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features." @default.
• Q46138991 prefLabel "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features." @default.
• Q46138991 P1433 Q46138991-59BB11EC-F9E9-47F5-9BE9-90F2E052C426 @default.
• Q46138991 P1476 Q46138991-65DA7B93-C921-4956-B364-9FF55B5174D5 @default.
• Q46138991 P2093 Q46138991-7FF52460-9FBE-4651-A34D-81C873515D08 @default.
• Q46138991 P2093 Q46138991-8D643170-D07B-4E63-8E0D-85254114A873 @default.
• Q46138991 P2093 Q46138991-8EF1683E-3B9C-4306-A8AB-2F17E3F8F976 @default.
• Q46138991 P2093 Q46138991-D233EE77-996A-411C-97A8-8477AF22C89E @default.
• Q46138991 P2093 Q46138991-F2B4E207-0859-40BB-93E2-775C83E4204D @default.
• Q46138991 P304 Q46138991-66CD9949-35EB-4B07-B3C0-362F849EDD1F @default.
• Q46138991 P31 Q46138991-D8F9A7CE-07E0-44D9-B4C2-7BD39C5EF637 @default.
• Q46138991 P356 Q46138991-323711CE-6E8E-4C62-BE37-E369E0271DD2 @default.
• Q46138991 P433 Q46138991-0332D564-9638-4B68-833A-B35AF1644F6B @default.
• Q46138991 P478 Q46138991-60E93F0D-A8AD-43CD-A195-753C99805382 @default.
• Q46138991 P50 Q46138991-2D47CE77-143F-47E2-80A1-84C1F18F778A @default.
• Q46138991 P50 Q46138991-2F6CC50A-9245-4629-8114-E5F9C8FF0366 @default.
• Q46138991 P50 Q46138991-58A3789A-8494-4A88-BE39-C1D3F385773D @default.
• Q46138991 P50 Q46138991-723A5DF0-75C6-40FE-AB8A-31CE34320A4A @default.
• Q46138991 P50 Q46138991-8DF399BD-36C5-42FF-8C06-A38E114DED44 @default.
• Q46138991 P50 Q46138991-A70867D1-09CC-41E7-B9AA-098FF5EA9945 @default.
• Q46138991 P50 Q46138991-CB7141B8-FA3E-4837-9819-26ECE7DC0BD3 @default.
• Q46138991 P50 Q46138991-F5F1DF9B-91CB-4CC0-A3D7-5293DAB42488 @default.
• Q46138991 P577 Q46138991-C3E329D5-C402-4A22-BCDE-C02EC71CCC49 @default.
• Q46138991 P698 Q46138991-14A880A1-27E6-4865-B217-C65C8523A345 @default.
• Q46138991 P921 Q46138991-4A88B300-7172-40DB-8259-03D2D6E7241F @default.
• Q46138991 P921 Q46138991-7E513FDA-2FFF-405A-93F7-73DF24753E47 @default.
• Q46138991 P921 Q46138991-8BF0D155-271F-491D-9092-E838B9540CD3 @default.
• Q46138991 P921 Q46138991-C886EAE6-84CB-4049-9024-87780BED3878 @default.
• Q46138991 P356 CAD.0B013E3283264719 @default.
• Q46138991 P698 19182679 @default.
• Q46138991 P1433 Q4774128 @default.
• Q46138991 P1476 "Infusional fluorouracil, epirubicin, and cisplatin followed by weekly paclitaxel plus bevacizumab in locally advanced breast cancer with unfavorable prognostic features" @default.
• Q46138991 P2093 "Alessandra Balduzzi" @default.
• Q46138991 P2093 "Anna Cardillo" @default.
• Q46138991 P2093 "Aron Goldhirsch" @default.
• Q46138991 P2093 "Emilia Montagna" @default.
• Q46138991 P2093 "Vincenzo Bagnardi" @default.

• next